Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
Top Cited Papers
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 85 (1), 75-90
- https://doi.org/10.1016/j.antiviral.2009.09.008
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- Vaginal microbicides and the prevention of HIV transmissionThe Lancet Infectious Diseases, 2008
- HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivoVirus Research, 2008
- Novel HIV-1 reverse transcriptase inhibitorsVirus Research, 2008
- Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptaseVirus Research, 2008
- Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitorsVirus Research, 2008
- High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutationsProceedings of the National Academy of Sciences of the United States of America, 2008
- Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo cityVirus Research, 2007
- Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistanceProceedings of the National Academy of Sciences of the United States of America, 2007
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Survival with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987